Skip to main content

Radionetics Oncology

California City, United States

Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.

$52.5M raised
Aug 2023
Series A

Top Investors

5AM VenturesFrazier Healthcare PartnersDCVC BioFrazier Life SciencesCrinetics Pharmaceuticals

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Radionetics Oncology

How much funding has Radionetics Oncology raised?
Radionetics Oncology has raised $52.5M in total funding. The most recent round was Series A. The last funding was announced in August 2023.
Who are Radionetics Oncology's investors?
Radionetics Oncology's investors include 5AM Ventures, Frazier Healthcare Partners, DCVC Bio, Frazier Life Sciences, Crinetics Pharmaceuticals.
Where is Radionetics Oncology headquartered?
Radionetics Oncology is headquartered in California City, United States.
What does Radionetics Oncology do?
Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.
What stage is Radionetics Oncology at?
Radionetics Oncology is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Radionetics Oncology — Funding & Investors." VCBacked, August 14, 2023, https://www.vcbacked.co/company/radionetics-oncology. Accessed June 17, 2026.
APA
VCBacked. (2023). Radionetics Oncology — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/radionetics-oncology
Wikipedia (cite web)
{{cite web |title=Radionetics Oncology — Funding & Investors |url=https://www.vcbacked.co/company/radionetics-oncology |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .